Michael R. Megna, CAO of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $2.3M. The latest trade was on 04/09.

Michael R. Megna

Chief Accounting Officer

Company: Kiniksa Pharmaceuticals International KNSA
First filing: 23/03/20

Trades: 145 trades
Buys / sales: 0 / 14
12-month net buying: −$2.3M
Last trade: 04/09

Trading activity

Transactions

	Trade type
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	04/09	04/13	6,625 sh	$46.69	$309,321.25	−19.5%
KNSA	Open-market sale10b5-1 plan	25/10/20	25/10/22	50,490 sh2 trades	$38.87avg.	$1,962,781.45	−65.1%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/09/03	25/09/03	11,000 sh	$34.84	$383,240	−22.4%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/08/04	25/08/06	17,000 sh	$32.35	$549,950	−34.0%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/06/03	25/06/05	15,211 sh	$28.75	$437,316.25	−31.9%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/05/07	25/05/09	17,647 sh	$26.69	$470,998.43	−35.2%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/03/12	25/03/14	9,051 sh	$22.45	$203,194.95	−25.4%
KNSA	Open-market sale10b5-1 plan	24/11/27–24/11/29	24/12/02	8,646 sh2 trades	$22.45avg.	$194,102.7	−24.6%
KNSA	Open-market sale10b5-1 plan	24/02/28–24/03/01	24/03/01	14,785 sh2 trades	$21.57avg.	$318,881.09	−45.7%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	24/01/02	24/01/04	16,670 sh	$19.17	$319,563.9	−49.5%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	23/12/19	23/12/21	9,316 sh	$19.13	$178,215.08	−35.4%